RAPT Therapeutics Inc. (RAPT) stock soars during current market trading. Stated below is the update
RAPT Therapeutics Inc. (NASDAQ: RAPT) stock gained by 85.46% in the current market trading. RAPT Therapeutics is a clinical-stage immunology-based pharmaceutical business focusing on finding, developing, and promoting oral small molecule medicines for cancer and inflammatory disorders patients with large unmet needs. Important Development RPT193 as monotherapy was found to be effective in 31 patients […]
